Trinity Biotech Depreciation & Amortization Growth & History (TRIB)

Trinity Biotech's depreciation and amortization was $2.7M for fiscal 2025.

View full Trinity Biotech company overview

Trinity Biotech annual depreciation and amortization history

Trinity Biotech annual depreciation and amortization

Fiscal yearPeriod endedDepreciation and amortizationChangeGrowth
20252025-12-31$2.7M$2.5M+1215.69%
20242024-12-31$204,000$204,000
20232023-12-31$0$0
20222022-12-31$0−$38.0M
20212021-12-31$38.0M$38.0M+94900.00%
20202020-12-31$40,000$36,000+900.00%
20192019-12-31$4,000−$75,000−94.94%
20182018-12-31$79,000−$449,000−85.04%
20172017-12-31$528,000$114,000+27.54%
20162016-12-31$414,000$346,000+508.82%
20152015-12-31$68,000

Trinity Biotech depreciation and amortization trends

Over the last five fiscal years, Trinity Biotech's depreciation and amortization increased from $40,000 to $2.7M, a change of $2.6M. The latest reported quarter, Q4 2024, shows $424,000.

About the metric

What depreciation and amortization mean

Depreciation and amortization allocate the cost of tangible and intangible assets over their useful lives. These non-cash expenses reduce reported earnings and are commonly added back when calculating EBITDA and operating cash flow.

Calculation and source

Reported depreciation and amortization

TickerStat uses a combined depreciation and amortization value when reported. If a company reports the two components separately for an aligned period, they are added together without duplicating overlapping facts. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Trinity Biotech source filings ↗

Community posts

It’s quiet here.

No posts about TRIB yet. Start the conversation.

Write the first post